MUTUAL SETTLEMENT, RELEASE AND MEDIA LICENSE AGREEMENTMutual Settlement, Release and Media License Agreement • November 6th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
THIS MUTUAL SETTLEMENT AND RELEASE AGREEMENT is made on December 21, 2016, (the “Effective Date”), by and between Boehringer Ingelheim Biopharmaceuticals GmbH, a German corporation, having its principal place of business at Binger Straße 173, 55216 Ingelheim am Rhein, Germany (“BI”), and River Vision Development Corp., having its principal place of business at One Rockefeller Plaza, Suite 1204, New York, NY 10020, USA (“RVDC”), (each Party hereinafter referred to as a “Party” and both Parties collectively referred to as the “Parties”).
